BioTech Health XSeptember 19, 2022 Biotech NewsVirios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results 5 minute read In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome… 0 Shares 0 0 0 0 0 0 0
BioTech Health XSeptember 14, 2022 Biotech NewsCEL-SCI Multikine Phase 3 Data Highlighted at ESMO 2022 8 minute read CEL-SCI recently presented its Phase 3 data at ESMO 2022, which revealed that Neoadjuvant Multikine achieved groundbreaking tumor… 0 Shares 0 0 0 0 0 0 0
BioTech Health XSeptember 3, 2022 Biotech NewsMayo Clinic, Hibiscus BioVentures, and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator 4 minute read Mayo Clinic, Hibiscus BioVentures (Hibiscus), and Innoforce have announced the formation of Mayflower BioVentures, a cell and gene… 0 Shares 0 0 0 0 0 0 0
BioTech Health XSeptember 2, 2022 BioTech CEO InterviewsSyneuRx CEO Dr. Emil Tsai Exclusive Interview with Insights & Projections 8 minute read Our BioTech Health X CEO Series continues with an exclusive interview with Dr. Emil Tsai of SyneuRx. Today… 11 Shares 11 0 0 0 0 0 0